Member Info for violindog

....and despite this...no market interest in SCLP today :(

Thanks Konar, my bubble burst too ! Well, with luck we are almost there .

Chester, interested by your thoughts and time line. My only comment "3-4weeks to screen patients " I don't think it would take this long. Quick antibody test to see/ note previous Covid exposure (are there almost instant tests nowdays?) along side a set of renal/ bone/ liver and clotting (very quick turn around for these) ...detailed history take....then jab ..
Thoughts on this anyone ?

Hi Chester, guess we are all just waiting for the trial start RNS s

Exactly, trial start RNS would be good to start with ! WHEN is it coming!

WTP... I agree with both you and Hasiba. This really is the crunch time for SCLP. Everything has come to this piviotal point: trials / data /deals (not necessarily in that order) I'm fed up of all the NDA's and desperately want a decent return on this investment. Hopefully everything has come together at the right time. Both SCLP and big pharma must get a sniff of how Covidity and Modi1 are doing by the end of H1 next year. If no deals by then then... is it time to follow DE ??

Great summary Chester ! and most of those inflection points could transform SCLP .
Really wish we could get the first pt injected RNS for points 1+2 ASAP. Covidity trial in SA must be near to starting one would have thought. Tick tock as they say.

Crumbs....thanks for clearing that up for me ..you are correct : )

Crumbs, I'm all for SCLP developing the platform in house and adding value... but this " deal "is subjective. SCLP never told shareholders we have been offered £x but with Redmile funding we can achieve £Y so the deal is off. If they had the share price would have increased even if SCLP didn't name the company or amount as per a NDA .

LL, so that was 2 years ago....and the only update we have had since this was inked is your reminder of the original...least we forget : )))

Roses, why are you confident it was a buy..it wasn't a buy at the closing bell...its a "delayed trade" so unless one knows the time of the trade could have been either surely??:

WTP, some odd trades today indeed. Irritating we can swing in value and be controlled by "the seller" on relatively small volumes. Appreciate the underlying asset is sound and it may give some a lower entry but I would love to see a steady sustained rise rather than being walked up one day and down the next. Guess one just has to grin and bear it with such a small free float and wait for the trials to reflect true value. On that note...hopefully very soon!
From what I know about ITU beds in the UK currently, it's the lack of ITU nursing staff...not the physical capacity of beds . So many left after Covid and it takes at least a year to train an ITU nurse from scratch. Having said that....clinical trials generate ££ and £ comes first these days . Any clinical trial "emergency" would simply be classed as an in house event and an ITU bed provided if required. I don't think we need to consider lack of ITU beds as a constraint for trials. I have sat at enough Critical capacity bed meetings deciding what operations are given the go ahead...NEVER was an ITU bed ring-fenced for a trial patient "just in case" . No.... large teaching hospitals simply see clinical trials as income generation.

Seller back today... sells closely timed together and a strange run of trades timed from 10:07 .
Had hoped the "seller "was done.

Moon, hope the seller has finished...finally. Last time we had a decent rise, DE, I mean the seller, was out in force the following day. So tomorrow if we hold today's gain I will be very happy.

Ivy, do you think we will get a "first patient vaccinated" RNS ?

DE said he was going to sell down his holdings, very soon after this statement we began to see very closely timed sells.....conclusion.....most likely DE.

Thanks Crumbs and 2cv
English literature was never a strong subject at school. I'm pleased that I " read " it wrong and thanks for your input. So 4 targets out of 4 ..brilliant for all those patients.

Thanks 2cv
Just on head / neck cancer I didn't realise it alone covered so many cancers : ((

Head and neck cancer is a general term that covers many different types of cancer including:

Nasal and paranasal sinus cancer
Mouth and oropharyngeal cancer
Laryngeal cancer
Oesophageal cancer
Salivary gland cancer
Tonsil cancer
Nasopharyngeal cancer
Throat cancer

Delighted by today's announcement. Just to clarify...although approved for the four targets, breast, renal, ovarian and head/neck , SCLP are only going for head/neck and renal in this first wave? Is this correct? Why would this be ? Or are the other targets getting Modi1 as stand alone treatment with no check point inhibitors?
Quote from the RNS
"First-in-human clinical trial in patients with triple negative breast cancer, ovarian cancer, head and neck cancer, and renal cancer
Modi-1 to be administered in combination with checkpoint inhibitors in patients with head and neck or renal tumours:

Well someone is selling depressing the share , most of yesterday's gain gone : ((
To quote "it's the amount you hold " when the end game arrives...so trying not to stress about daily fluctuations.